A guy on Instagram told me last week that shining red light on his testicles doubled his testosterone. He had 47,000 followers. He was standing shirtless in front of a panel that costs more than my first car. And his evidence was — I'm quoting here — "I just feel it, bro."

That's where we are with red light therapy in 2026.

Here's the thing. Photobiomodulation is real science. It has thousands of published papers. It has legitimate clinical applications that have been studied for decades. But somewhere between the research labs at Harvard and the influencer studios in Austin, the story went completely sideways. The actual science got buried under a mountain of marketing claims, affiliate codes, and shirtless dudes standing in front of LED panels like they're charging their bodies at a Tesla Supercharger.

I've spent the last three months reading through the photobiomodulation literature — the actual peer-reviewed stuff, not the blog posts — and the picture that emerges is genuinely interesting. Just not in the way the panel companies want you to think.

Photobiomodulation, or PBM, operates on a mechanism that's been understood at the cellular level since the late 1990s. Red light in the 630–670nm wavelength range and near-infrared light in the 810–850nm range penetrate the skin and are absorbed by a specific enzyme in your mitochondria called cytochrome c oxidase. This is Complex IV of the electron transport chain. When photons at these wavelengths hit cytochrome c oxidase, they dissociate nitric oxide from the enzyme's binding site, which has been inhibiting its function. Free the enzyme from that nitric oxide block, and you restore normal mitochondrial respiration. More ATP production. More cellular energy.

That's not pseudoscience. That's biochemistry.

Dr. Michael Hamblin at Harvard — probably the most published PBM researcher in the world, with over 400 papers on the topic — has spent his career mapping these mechanisms. His work has shown that the downstream effects of this mitochondrial stimulation include reduced reactive oxygen species, activation of transcription factors like NF-kB, and modulation of inflammatory cytokines. The cell gets a metabolic boost. Inflammation decreases. Tissue repair accelerates.

On paper, it sounds like a miracle. In practice, the details matter enormously. And this is where the consumer market falls apart.

Let me be honest about where PBM has decent evidence, because it does. Just not for the things most people buy panels for.

Wound healing. This is probably the strongest application in the literature. A 2014 systematic review by Avci et al. in Seminars in Cutaneous Medicine and Surgery examined the evidence for PBM across dermatological conditions and found consistent support for accelerated wound repair. Multiple RCTs have shown that red and near-infrared light at appropriate doses speed healing in chronic wounds, surgical incisions, and oral mucositis in cancer patients undergoing radiation. The military has studied this extensively — the Uniformed Services University funded research on PBM for combat wound healing, and the results were positive enough to warrant further investigation.

Joint pain and osteoarthritis. A 2015 Cochrane-style review published in the Journal of Rheumatology looked at low-level laser therapy for osteoarthritis of the knee. The meta-analysis found statistically significant reductions in pain and improvements in function compared to placebo. Not earth-shattering effect sizes, but real ones. Repeated across multiple trials. The World Association for Photobiomodulation Therapy released dosing guidelines specifically for musculoskeletal conditions.

Skin health and collagen production. A 2014 RCT by Wunsch and Matuschka in Photomedicine and Laser Surgery treated subjects with 611–650nm red light twice weekly for 30 sessions. The treatment group showed measurably increased collagen density, reduced wrinkle severity, and improved skin complexion compared to controls. This wasn't subjective self-reporting. They used objective skin roughness measurements and ultrasound to quantify collagen changes.

Hair loss. This one surprised me, but the evidence is reasonably solid for androgenetic alopecia specifically. A 2014 randomized, double-blind, sham device-controlled trial by Lanzafame et al. in Lasers in Surgery and Medicine found a 39% increase in hair count after 16 weeks of red light treatment in men with pattern hair loss. The FDA has actually cleared several low-level laser therapy devices for hair loss, which — whatever you think of the FDA's clearance process — at least means some minimum evidentiary threshold was met.

That's the list. Wound healing. Joint pain. Skin. Hair. Not sexy. Not revolutionary. But supported by actual controlled trials with measurable outcomes.

Now for the part that's going to make some people angry.

Testosterone boosting. This claim traces back primarily to a 2013 pilot study by Woo et al. that exposed a small group of men to red light and measured subsequent testosterone changes. The study had no control group. The sample size was tiny. The methodology was, to put it charitably, preliminary. To put it less charitably, it was the kind of study you'd run to decide whether a real study was even worth doing — not the kind you'd base a purchasing decision on. But it became gospel in certain corners of the internet because testosterone is the ultimate male biohacking keyword, and "shine this light on yourself and watch your T levels rise" is an irresistible narrative. One small, poorly controlled study does not constitute evidence. Period.

Systemic fat loss. There are a handful of studies showing that PBM can affect adipocyte function in vitro — in isolated fat cells in a petri dish. Extrapolating from "this affects fat cells in a lab" to "standing in front of an LED panel will make you lose body fat" is a logical leap that would embarrass a first-year biology student. The clinical trials on PBM for body composition are sparse, small, and inconsistent. A 2011 study by Jackson et al. showed some waist circumference reduction, but the effect was modest and the methodology has been questioned. You'd get more reliable fat loss from walking 30 minutes a day.

Cognitive enhancement from panels. I've seen companies claiming their full-body panels improve focus, memory, and mental clarity. The research on transcranial PBM — light applied directly to the scalp targeting brain tissue — does show some promise in early-stage studies on traumatic brain injury and possibly depression. But those studies use targeted devices applying specific doses to specific brain regions. They do not involve standing six feet from a wall-mounted LED panel and hoping some photons make it through your skull. The inverse square law is unforgiving. The intensity of light drops with the square of the distance. What reaches your prefrontal cortex from a panel across the room is essentially nothing.

This is the part that should make every panel owner uncomfortable. Dose matters in PBM more than almost any other variable, and most people using home devices are almost certainly not getting therapeutic doses.

The key metrics are irradiance — measured in milliwatts per square centimeter at the tissue surface — and fluence, measured in joules per square centimeter. The Hamblin group and others have consistently shown that PBM follows a biphasic dose response, sometimes called the Arndt-Schulz curve. Too little light does nothing. The right amount stimulates cellular function. Too much actually inhibits it. The therapeutic window is relatively narrow.

Most clinical studies showing positive results used irradiance values between 10 and 50 mW/cm² at the tissue surface, with fluence targets of 1 to 10 J/cm² depending on the condition. Here's the problem: those values were achieved with the light source inches from the skin, often in direct contact. When you stand two or three feet from your panel — which is what most manufacturers recommend — the irradiance at your skin drops dramatically. A panel advertising 100 mW/cm² at the surface might deliver 15–20 mW/cm² at 18 inches. At three feet? Maybe 5 mW/cm². You might be standing there for your dutiful 10-minute session and getting a dose that falls below the therapeutic threshold entirely.

And there's another problem that rarely gets discussed. The vast majority of the high-quality PBM research — the stuff that actually shows clear, replicable effects — was done with lasers. Not LEDs. Lasers produce coherent light with a specific beam profile. LEDs produce incoherent light that scatters. Whether coherence matters for the biological effect is genuinely debated in the literature — some researchers say no, some say yes — but the fact remains that when you buy an LED panel and point to a study done with a laser device, you're assuming equivalence that hasn't been firmly established. It might be equivalent. It might not. The honest answer is we don't fully know yet.

I was sitting in my garage the other day — I'd been comparing panel specs for about three hours at that point, which is the kind of Saturday night that makes my wife question her life choices — and I started looking at who promotes these devices.

The pattern is remarkably consistent. The biggest names in the red light therapy space — Ben Greenfield, various podcast hosts, Instagram biohackers with impressive physiques — almost all have affiliate deals or equity stakes in panel companies. Ben Greenfield has promoted Joovv extensively. Other influencers have their own preferred brands. The panels they recommend happen to cost $1,000 to $2,000 or more.

That doesn't automatically mean they're wrong. But it does mean you should apply the same skepticism you'd apply to any salesperson. When someone with a financial incentive tells you a $2,000 device will change your life, and the evidence supporting their specific claims ranges from weak to nonexistent, the rational move is to take a very large step back.

Here's what I'll say plainly: a $200 panel from a reputable manufacturer uses the same LEDs, the same wavelengths, and delivers the same photons as a $2,000 panel. The expensive ones might cover a larger surface area, which saves you time if you're treating your whole body. They might have slightly better build quality. But the light itself is the same. A 660nm photon doesn't know how much you paid for it. Physics doesn't have a luxury tier. If you want to try PBM for its evidence-backed uses, there are solid red light panels on Amazon starting around $100 that deliver the same wavelengths as the premium brands.

Red light therapy is real science with real applications. I believe that. The mechanisms are well-characterized. The evidence for wound healing, joint pain, skin health, and hair loss is legitimate. If you have chronic knee pain from osteoarthritis, a red light device applied directly to the joint at appropriate doses is a reasonable intervention supported by multiple controlled trials.

But the consumer market around PBM is roughly 90% marketing and 10% evidence. The legitimate uses are boring — they don't sell $2,000 panels. Nobody's going viral on Instagram posting "my surgical wound healed 15% faster." The sexy claims — fat loss, testosterone, cognitive enhancement, systemic anti-aging — are either weakly supported or completely unsupported at the doses and delivery methods that consumer panels provide.

If you're going to use red light therapy, use it for what the evidence actually supports. Apply it close to the target tissue. Pay attention to dose. Don't spend $2,000 when $200 buys you the same wavelengths. And for the love of everything, don't shine it on your testicles because a guy on Instagram told you to.

The foundation of any recovery and skin health protocol starts with what you put into your body, not what you shine on it. If you're serious about collagen production and managing inflammation — the two areas where PBM actually has evidence — your baseline should be adequate omega-3 intake and quality collagen support. Thorne makes some of the best-tested supplements I've found for both, and that's a far better investment than an overpriced light panel.

Here's what I keep coming back to: if photobiomodulation is as powerful as the panel companies claim, why are the best-supported uses the ones nobody wants to talk about? And what does it tell us about this industry that the loudest voices have the biggest financial incentives?

What's your experience been — has red light therapy actually moved the needle for you, or are you starting to wonder if you bought a very expensive nightlight?